Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions (Q47448610)

16 January 2018

title

Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions (English)

1 reference

16 January 2018

1 reference

Lars A Akslen

1 reference

16 January 2018

Jone Trovik

1 reference

16 January 2018

Camilla Krakstad

1 reference

16 January 2018

Helga Salvesen

object named as

Helga B Salvesen

1 reference

16 January 2018

Therese Bredholt

object named as

Therese Bredholt

1 reference

16 January 2018

Henrica M J Werner

object named as

Henrica M J Werner

1 reference

16 January 2018

author name string

Tina Fonnes

1 reference

16 January 2018

Hege F Berg

1 reference

16 January 2018

Per-Henrik D Edqvist

1 reference

16 January 2018

Kristina Sortland

1 reference

16 January 2018

Anna Berg

1 reference

16 January 2018

Ingvild L Tangen

1 reference

16 January 2018

language of work or name

English

0 references

publication date

30 October 2017

1 reference

16 January 2018

published in

Gynecologic Oncology

1 reference

16 January 2018

volume

148

1 reference

16 January 2018

issue

1 reference

16 January 2018

page(s)

197-203

1 reference

16 January 2018

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

Markers for individualised therapy in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

Advances in the management of recurrent endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

Recent and current Phase II clinical trials in endometrial cancer: review of the state of art.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

The human asparaginase-like protein 1 hASRGL1 is an Ntn hydrolase with beta-aspartyl peptidase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

A novel asparaginase-like protein is a sperm autoantigen in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

Switch in FOXA1 status associates with endometrial cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

Prognostic biomarkers in endometrial and ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

Validation of new cancer biomarkers: a position statement from the European group on tumor markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

Uterine neoplasms, version 1.2014.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

Lack of estrogen receptor-α is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

Current status of molecular biomarkers in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

Androgen receptor as potential therapeutic target in metastatic endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

Human pancreatic carcinoma (MIA PaCa-2) in continuous culture: sensitivity to asparaginase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

L-asparaginase inhibits invasive and angiogenic activity and induces autophagy in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

Asparagine Synthetase Expression and Phase I Study With L-Asparaginase Encapsulated in Red Blood Cells in Patients With Pancreatic Adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2017.10.025

10.1016/J.YGYNO.2017.10.025

7 January 2021

Identifiers

DOI

1 reference

16 January 2018

1 reference

16 January 2018